Page last updated: 2024-10-22

amifostine anhydrous and Caries, Dental

amifostine anhydrous has been researched along with Caries, Dental in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shiboski, CH1
Hodgson, TA1
Ship, JA1
Schiødt, M1
Rudat, V1
Meyer, J1
Momm, F1
Bendel, M1
Henke, M1
Strnad, V1
Grötz, K1
Schulte, A1

Reviews

1 review available for amifostine anhydrous and Caries, Dental

ArticleYear
Management of salivary hypofunction during and after radiotherapy.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103 Suppl

    Topics: Amifostine; Dental Caries; Humans; Muscarinic Agonists; Pilocarpine; Radiation Injuries; Radiation-P

2007

Trials

1 trial available for amifostine anhydrous and Caries, Dental

ArticleYear
Protective effect of amifostine on dental health after radiotherapy of the head and neck.
    International journal of radiation oncology, biology, physics, 2000, Dec-01, Volume: 48, Issue:5

    Topics: Adult; Aged; Amifostine; Dental Caries; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged;

2000